Home/Filings/4/0001104659-23-092080
4//SEC Filing

Drutz David 4

Accession 0001104659-23-092080

CIK 0001326190other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 6:46 PM ET

Size

5.2 KB

Accession

0001104659-23-092080

Insider Transaction Report

Form 4
Period: 2023-08-15
Drutz David
Director
Transactions
  • Purchase

    Common Stock, par value $0.0001

    2023-08-15$2.88/sh+300$86329,785 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC.
  • [F2]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001428764

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 6:46 PM ET
Size
5.2 KB